Onxeo: Publication of the 2018 Registration Document

Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), a biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced the publication of the Company’s 2018 Registration Document. The 2018 Registration Document, filed with the French Market Authorities (Autorité des Marchés Financiers)